%0 Journal Article
%T 循环浆细胞在多发性骨髓瘤中的临床价值及其形成机制<br>The Clinical Value and Mechanism of Circulating Plasma Cells in Multiple Myeloma
%A 王鹏
%A 张丽洁
%J Advances in Clinical Medicine
%P 428-434
%@ 2161-8720
%D 2024
%I Hans Publishing
%R 10.12677/acm.2024.1461792
%X 长期以来，循环浆细胞(circulating plasma cell, CPC)的存在一直被认为是多发性骨髓瘤(multiple myeloma, MM)中有价值的预后生物标志物。多项研究表明，CPC检测可用于监测肿瘤负荷，高CPC水平可以预测治疗反应差和不良结局的高危MM。但是CPC的形成机制目前还尚未明确。本文对CPC在MM中的临床价值及CPC形成的可能机制进行综述。<br />
The presence of circulating plasma cells (CPC) has long been considered a valuable prognostic biomarker in multiple myeloma (MM). Multiple studies have shown that CPC detection can be used to monitor tumor burden, and high CPC levels can predict high-risk MM for poor treatment response and adverse outcomes. However, the mechanism of CPC formation is still unclear. This article reviews the clinical value of CPC in MM and the possible mechanism of CPC formation.
%K 循环浆细胞，多发性骨髓瘤，综述<br>Circulating Plasma Cells
%K Multiple Myeloma
%K Reviews
%U http://www.hanspub.org/journal/PaperInformation.aspx?PaperID=89231